More News! 19 Nov 2018 Anti-Inflammatory Treatments Get €40M Boost in Series B A Series B funding round has whipped up €40M for the Irish company Inflazome. This money will help to fund clinical trials for anti-inflammatory treatments targeting conditions such as Alzheimer’s… November 19, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2024 AI and a brain organoid: can this combo take on supercomputers? …because mouse models that are advanced and contain humanized sequences have fallen short of capturing Alzheimer’s disease pathology. These organoids are capable of simulating the environment in an Alzheimer’s brain,… January 12, 2024 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
2024 biotech deals tracker: the latest partnerships and M&A …United Kingdom, are teaming up to develop Alzheimer’s disease treatments. Muna is eligible to receive €33.5 million ($35.17 million) upfront and up to €140 million ($147 million) in milestone payments…. March 7, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 16 Oct 2017 Interview: On the Future of iPS Cells and why Partnering is so Important in this Field …covering diseases such as ALS, Parkinson’s, Alzheimer’s and Huntington’s. We have developed differentiation protocols to generate relevant neuronal cell types and we are investigating the cellular effects of the various… October 16, 2017 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Aug 2025 Five biotech companies in South Korea you should know about …areas: Cancer, eye disorders, and Alzheimer’s disease Specializing in RNA therapeutics, Rznomics has built a platform that has several features, including its ability to inhibit the expression of disease-specific genes and… August 26, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Apr 2025 21 UK biotech companies you should know about …degrader molecules called “TRIMTACs.” The company’s pipeline is focused on treatments for severe neurodegenerative disorders, including Alzheimer’s and Huntington’s disease. Working across the MRC Laboratory of Molecular Biology (LMB) and… April 24, 2025 - 27 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Jan 2023 The biggest private biotech investments in December 2022 …Eisai for the Alzheimer’s drug lecanemab. This is the latest in a small number of drugs that could slow down the development of Alzheimer’s rather than just improving the symptoms…. January 9, 2023 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Biotech conferences and events …York, US 10-12 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting, Boston, US 29-December 1 CRISPR 2.0 Boston, US 29-December 2 Clinical Trials on Alzheimer’s Disease international conference, San… September 1, 2022 - 2 minutesmins - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Jan 2024 Five biotech companies taking Florida by storm …donors. The company is currently conducting phase 1 and 2 trials for aging frailty, Alzheimer’s disease, metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). In… January 16, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jul 2017 FREE White Paper! All You need to Know about Omics and Body Fat …as obesity, diabetes, Alzheimer’s and cardiovascular diseases, biomarkers are becoming the centre of attention. Some of these bad guys are lipid molecules, which can be studied through lipidomics, a research… July 19, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 Silo Pharma looks into the 2023 psychedelics crystal ball …a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease, and other rare neurological disorders. What breakthroughs do… January 11, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2022 Human cells can now help scientists accelerate cure for neurodegenerative diseases …like Alzheimer’s disease (AD), Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) has been challenging. Transform research Scientists have had to rely on animal models and cell lines that are… September 29, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email